Neuropeptide Thyroliberin - Adaptive Endogenous Anticonvulsant Defense of Brain

Uspekhi Fiziologicheskikh Nauk

Volumn 33, Issue 1, 2002, Pages 37-39

  Chepurnov, S A ^a   Chepurnova, N E ^a   Abbasova, K R ^a   Goncharov, O B ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0041912423     PISSN: 03011798     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ashmarin I.P., Asanova L.M., Chepurnova N.E., Chepurnov S.A., Yatzuk S.L. Neuropeptides in the ultra low doses (Physiological bases for clinical application in Epilepsy) // Epilepsia. 1995. V. 36 (Suppl. 3). P. 44.
2. Baram T., Hatalski C.G. Neuropeptide-mediated excitability: a key triggering mechanisms of seizures generation in developing brain // TINS. 1998. V. 21. No 11. P. 471-476.
3. Begely D.J., Chain D.G. Clearance of glutamic acid, glutamine and pyroglutamic acid from the cerebrospinal fluid of the rabbit; a comparison with TRH // J. Physiol (L). 1982. V. 320. P. 22-23.
4. Chepurnov S.A., Krejcil, Baseer M. Shaikh, Mukiibi N.F., Tagirov N.S., Chepurnova N.E., Ashmarin I.P. The correction of seizures of limbic structures by neuropeptides and immunization to antidepressants // Constituent Congress Intern. Soc. Pathophysiol., Moscow, 1991. P. 18.
5. Chepurnov S.A., Chepurnova N.E., P.Chandra Kumar, Abbasova K.R., Turbovskaya E.Ja., Ashmarin I.P. Thyrotropin releasing hormone in ultra low doses increases convulsion threshold in the rats // 2nd Inter. Congr. on Ultra Low Doses. Bordeaux, 1993. P. 34.
6. Chepurnov S.A., Chepurnova N.E., Asanova L.M., Ashmarin I.P. Anticonvulsant neuropeptide TRH - adaptive endogenous defence of brain. Treatment for epilepsy in chidhood // Epileptologia (Warsaw). 1999. V. 7 (Suppl.). P. 86-87.
7. Chepurnova N.E., Chepurnov S.A., Goncharov O.B. Intranasal Application of pGlu-His-Pro but not His-Pro inhibtis epileptic experimental fits // Epilepsia. 1999. V. 40 (Supl. 2) P. 126.
8. Inanaga A., Kumashiro H., Fukuyama Y., Ohtahara Sh., Shirouzu M. Clinical study of oral administration of DN-1417, a TRH analog in patient with interictal epilepsy // Epilepsia. 1989. V. 30. No 4. P. 438-445.
9. Franceschetti S., Panzica F.D., Sancini G., Avanzini G. Postnatal neocortical development maturational changes in the intrinsic properties of pyramydal neurons and their possible significance for epileptogenesis // Molecular and cellular targets for anti-epileptic drugs / Eds.: Avanzini G., Regesta G., Tanganelli P., Avoli M. 1997. P. 79-90.
10. Kubova H., Maresh P. Anticonvulsant effects of phenobarbital and primidone during ontogenesis in rats // Epilepsy Res. 1991. V. 10. P. 148-155.
11. Laakkonen L., Guarnieri G., Perlman J., Gershengorn G., Osman R. A refined model of TRH receptor binding pocket. Novel mixed Monte Carlo/Stochastic dynamic stimulatios of the complex between TRH and TRH receptors // Biochemistry. 1996. V. 35. No 24. P. 7651-7663.
12. Majkowski J. Interaction between new and old generation of antiepileptic drugs // Epileptologia (Warszawa). 1994. V. 2 (Supl.1). P. 33-42.
13. Mares P., Pohl M. Flunarizine-influences metrazol-induced seizures during ontogenesis in rats // Epilepsy Res. 1987. V. 1 P. 302-305.
14. Matsumoto A., Kumagai T., Takeuchi T., Migazaki Sh., Watanabe K. Factors influencing effectiveness of TRH for severe epilepsy in childhood: significance of serum prolactine levels // Eplepsia 1989. V. 30. No 1. P. 45-49.
15. Perlman J.H., Laakkonen L.J., Guarnier F., Osman R., Gershengorn M.C. A refined model of TRH receptor binding pocket. Experimental analysis and energy minimization of the comples between TRH and TRH receptor // Biochemistry. 1996. V. 35. No 24. P. 7643-7656.
16. Post R.M., Weiss S.R.B. Kindling: Implications for the course and treatmentr of affective disorders // Anticonvulsants in Psychiatry / Eds. Modigh M., Robak O.N., Vestergsaard P.V. 1994. P. 113-137.
17. + channels and the molecular pathogenesis of epilepsy; implications for therapy // Trends Neurosci. 2000. V. 23. P. 393-398.
18. Rosen J.B., Cain C.J., Weiss S.R.B., Post R.M. Alterations in mRNA of enkephalin, dinorphin and TRH during amygdala kindling: an in situ hybrydisation study // Mol. Brain. Res. 1992. V.15. P. 247-255.
19. Rosen J.B., Abramovitz J.U., Post R.M. Co-localization of TRH and mRNA and Fos-like immunoreactivity in limbic structures following amygdala kindling // Mol. Cell. Neurosci. 1993. V. 4. P. 335-342.
20. Satin A., Pekary A.E., Lloyd R.L. TRH gene and implicated in the antidepressant mechanisms of seizures // Annal N.Y. Acad. Sci. 1995. V. 739. P. 135-153.
21. Schally A. Aspects of hypothalamic regulation of the pituitary gland. // Science. 1978. V. 202. P. 18-28.
22. Schickerova R., Mares P. Rhythmic metrazol activity in rats as a model of human absence // Acta Nervous Superior (Praha). 1989. V. 31. P. 16-20.
23. Schomburg L., Bauer K. The TRH-degradating ectoenzyme. // Peptidergic Neuron / Eds.: Krisch B., Mentlein R. Birkhauser Verlag Basel, 1996.
24. The WAG/Rij rat model of absence epilepsy / Eds.: Kuznetzova G., Coenen A., Chepurnov S., van Luijtelaar G. NICI. The Netherlands. 2000. 139 p.
25. Vergens M., Marescaux Ch., Depaulis A., Micheletti G., Warter J.-M. Spontaneous spilke-and-wave discharges in Wistar rats. // Generalised Eplepsy / Eds.: Avoli M., Gloor P., Kostopoulos G., Naquet R. Boston-Berlin, 1990. P. 238-253.
26. Zlokovich B.V.., Segal M.B., Begley D.S., Davson H., Rakic L., Permeability of the blood-cerebrospinal fluid and blood-brain barriers to TRH // Brain Res. 1985. V. 358. No 1. P. 191-199.